High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: A prospective 9-year follow-up study

Archives of Gerontology and Geriatrics

Volumn 60, Issue 1, 2015, Pages 112-117

  Kuoppamäki, Marikka ^a,b   Salminen, Marika ^a,c,d   Vahlberg, Tero ^a   Irjala, Kerttu ^e   Kivelä, Sirkka Liisa ^f   Räihä, Ismo ^a,g  

^a UNIVERSITY OF TURKU   (Finland)

^b Naantali Health Centre   (Finland)

^c Harkatie Health Centre   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e Mehilainen Oy   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g TURKU CITY HOSPITAL   (Finland)

Author keywords

Aged; High sensitive C reactive protein; Risk factors; Vascular disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ELDERLY CARE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; VASCULAR DISEASE; BLOOD; CARDIOVASCULAR DISEASES; MIDDLE AGED; PREDICTIVE VALUE; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84918510275     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2014.10.002     Document Type: Article

References (33)

1. Alberti K., Zimmet P., Shaw F. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062. IDF Epidemiology Task Force Consensus Group.
2. Cesari M., Penninx B.W.J.H., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 2003, 108:2317-2322.
3. Clarke R., Shipley M., Lewington S., Youngman L., Collins R., Marmot M., et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. American Journal of Epidemiology 1999, 150:341-353.
4. Corrado E., Rizzo M., Coppola G., Fattouch K., Novo G., Marturana I., et al. An update on the role of markers of inflammation in atherosclerosis. Journal of Atherosclerosis and Thrombosis 2010, 17:1-11.
5. Emerging Risk Factors Collaboration C-reactive protein and other circulation markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 2004, 350:1387-1397.
6. Eurostat. (2012). Accessed 12.11.12. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes%20_of_death_%20statistics.
7. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry 1972, 18:499-502.
8. Fulks M., Stout R.L., Dolan V.F. Association of cholesterol, LDL, HDL, cholesterol/HDL and triglyceride with all-cause mortality in life insurance applicants. Journal of Insurance Medicine 2009, 41:244-253.
9. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. American Journal of Medicine 1999, 106:506-512.
10. Inelman E.M., Coin G.S., Miotto F., Peruzza S., Enzi G. Can obesity be a risk factor in elderly people?. Obesity Reviews 2003, 4:147-155.
11. Isoaho R., Puolijoki H., Huhti E., Kivelä S.-L., Laippala P., Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respiratory Medicine 1994, 88:571-580.
12. Jenny N.S., French B., Arnold A.M., Strotmeyer E.S., Cushman M., Chaves P.H., et al. Long-term assessment of inflammation and healthy aging in late life: The Cardiovascular Health Study All Stars. Journal of Epidemiology 2012, 67:970-976.
13. Kizer J.R., Arnold A.M., Jenny N.S., Cushman M., Strotmeyer E.S., Ives D.G., et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: The Cardiovascular Health Study All Stars. Journal of Gerontology 2012, 66A:1100-1107.
14. Linna M., Ahotupa M., Löppönen M.K., Irjala K., Vasankari T. Circulating oxidised LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study. Age and Ageing 2013, 42:110-113.
15. Loikas S., Löppönen M., Suominen P., Møller J., Irjala K., Isoaho R., et al. RIA for serum holo-transcobalamin: Method evaluation in the clinical laboratory and reference interval. Clinical Chemistry 2003, 49:455-462.
16. Lopes-Virella M.F., Virella G. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Frontiers in Bioscience 2003, 8:S750-S768.
17. Löppönen M., Räihä I., Isoaho R., Vahlberg T., Kivelä S.-L. Diagnosing cognitive impairment and dementia in primary health care-a more active approach is needed. Age and Ageing 2003, 32:606-612.
18. Mora S., Musunuru K., Blumenthal R.S. The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines. Clinical Chemistry 2009, 55:219-228.
19. Musunuru K., Kral B.G., Blumenthal R.S., Fuster V., Campbell C.Y., Gluckman T.J., et al. The use of high sensitivity C-reactive protein in clinical practice Nature Clinical Practice. Cardiovascular Medicine 2008, 5:621-635.
20. NACB LMPG Committee Members National academy of clinical biochemistry laboratory medicine practice guidelines: Emerging biomarkers for primary prevention of cardiovascular disease. Clinical Chemistry 2009, 55:378-384.
21. National vital statistics reports 2012, http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf Accessed 10.11.12.
22. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003, 107:499-511.
23. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey methods 1982, World Health Organisation, Geneva. 2nd ed.
24. Sattar N., Murray H.M., McConnachie A., Blauw G.J., Bollen E.L., Buckley B.M., et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 2007, 115:981-989.
25. Scirica B.M., Morrow D.A. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 2006, 113:2128-2151.
26. Song X., Pikäniemi J., Gao W., Heine R.J., Pyörälä K., Söderberg S., et al. Relationship between body mass index and mortality among Europeans. European Journal of Clinical Nutrition 2012, 66:156-165.
27. Strandberg T., Tilvis R. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:1057-1060.
28. Takala T.I., Suominen P., Isoaho R., Kivelä S.-L., Löppönen M., Peltola O., et al. Iron-replete reference intervals to increase sensitivity of hematologic and iron status laboratory tests in the elderly. Clinical Chemistry 2004, 48:1586-1589.
29. The Emerging Risk Factor Collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010, 375:132-140.
30. The Emerging Risk Factor Collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine 2012, 367:1310-1320.
31. Preventive Services Task U.S.Force Using nontraditional risk factors to estimate risk for coronary heart disease. Annals of Internal Medicine 2009, 151:474-482.
32. Vishram J.K., Borglykke A., Andreasen A.H., Jeppesen J., Ibsen H., Jørgensen T., et al. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: The Monica, Risk, Genetics, Archiving, and Monograph (MORGAM) project. Hypertension 2012, 60:117-123.
33. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation Part 1: Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva.